Skyrizi is available in multiple forms, including single-dose prefilled pens and single-dose prefilled syringes. The typical dosages of Skyrizi may vary depending on which condition is being treated.
- SKYRIZI is now the only four-dose-a-year biologic for psoriasis with options to administer via a single-dose pen or prefilled syringe NORTH CHICAGO, Ill., Aug. 9, 2021 /PRNewswire/ -- AbbVie (NYSE: ...
Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis. The drug starts working after your first dose. The Food and Drug Administration (FDA) has approved Skyrizi to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results